Showing results (291-300 of 468) with videos related to

Sort By:
Pageof 47
The Lancet. Oncology|May 9, 2014
Addressing overdiagnosis and overtreatment in cancer: a prescription for changeLaura J Esserman, Ian M Thompson, Brian Reid, et al.
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 31, 2016
Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II DiabetesChen-Pin Wang, Donna M Lehman, Yui-Wing F Lam, et al.
Psychopharmacology|May 30, 2019
Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancerAlexandra M Sharp, Suphada Lertphinyowong, Samantha S Yee, et al.
BJU International|January 20, 2011
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancerSteven B Zeliadt, David F Penson, Carol M Moinpour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White menKathleen C Torkko, Adrie van Bokhoven, Phoung Mai, et al.
Cancer Causes & Control : CCC|November 22, 2015
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention TrialJeannette M Schenk, Cathee Till, Ann W Hsing, et al.
Oncotarget|October 27, 2016
TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hostsGuangcun Huang, Pawel A Osmulski, Hakim Bouamar, et al.
The Journal of Urology|February 13, 2014
Statin drug use is not associated with prostate cancer risk in men who are regularly screenedElizabeth A Platz, Catherine M Tangen, Phyllis J Goodman, et al.
The Prostate|June 22, 2016
Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention TrialIbrahim Kulac, Berrak Gumuskaya, Charles G Drake, et al.
Pageof 47